Rani Therapeutics Stock Quote RANI - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

2.93

Bid

2.80

Ask

3.25

Volume

47,157

2.84 Day's Range 3.095

1.82 52 Week Range 8.75

Market Cap

147.732M

Previous Close

2.87

Open

2.87

Last Trade

2.8

Last Trade Time

Financial Volume

$ 140,633

VWAP

2.9822

Average Volume (3m)

82,622

Shares Outstanding

50,420,315

Dividend Yield

PE Ratio

-4.26

Earnings Per Share (EPS)

-0.67

Revenue

Net Profit

-33.97M

Rani Therapeutics Holdings Inc is a clinical stage biotherapeutics company advancing technologies to enable the development of orally administered biologics. The company has developed the RaniPill capsule, a proprietary and patented platform technology, intended to replace subcutaneous or IV injecti... Rani Therapeutics Holdings Inc is a clinical stage biotherapeutics company advancing technologies to enable the development of orally administered biologics. The company has developed the RaniPill capsule, a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.ranitherapeutics.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Rani Therapeutics Holdings Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker RANI. The last closing price for Rani Therapeutics was $2.87. Over the last year, Rani Therapeutics shares have traded in a share price range of $ 1.82 to $ 8.75.

Rani Therapeutics currently has 50,420,315 shares outstanding. The market capitalization of Rani Therapeutics is $144.71 million. Rani Therapeutics has a price to earnings ratio (PE ratio) of -4.26.

Form 8-K - Current report

Form 424B5 - Prospectus [Rule 424(b)(5)]

Rani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct Offering

SAN JOSE, Calif., July 22, 2024 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral...

Form 8-K - Current report

Rani Therapeutics Announces Partnership with ProGen on Development of Oral Obesity Treatment

~ New RT-114 obesity program combines ProGen’s FC Fusion protein conjugated GLP-1/GLP-2 dual agonist, PG-102, with the RaniPill® capsule designed to provide a differentiated oral delivery...

Form 8-K - Current report

Rani Therapeutics to Participate in May Investor Conferences

SAN JOSE, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral...

Rani Therapeutics to Present Clinical and Preclinical Data on Oral Delivery of an Ustekinumab Biosimilar via the RaniPill® Capsule at Digestive Disease Week 2024

SAN JOSE, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Rani Therapeutics Reports First Quarter 2024 Financial Results; Provides Corporate Update

- Announced Positive Topline Results from Phase 1 Study of an Oral Anti-Interleukin 12/23 Antibody (RT-111) - - Initiation of Phase 2 clinical trial for RT-102 for the treatment of osteoporosis...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.37	-11.2121212121	3.3	3.84	2.78	78144	3.05068127	CS
4	-0.89	-23.2984293194	3.82	4.19	2.78	54017	3.45466719	CS
12	-3.46	-54.1471048513	6.39	7.88	2.78	82622	5.15479513	CS
26	-0.69	-19.0607734807	3.62	8.75	2.78	108132	5.19571458	CS
52	-1.16	-28.3618581907	4.09	8.75	1.82	91287	4.25015393	CS
156	-8.33	-73.9786856128	11.26	36.27	1.82	84534	10.88498403	CS
260	-8.33	-73.9786856128	11.26	36.27	1.82	84534	10.88498403	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
WINTWindtree Therapeutics Inc	$ 8.24 (150.46%)	48.57M
BFIBurgerFi International Inc	$ 0.4206 (97.37%)	313.59M
NBSTWNewbury Street Acquisition Corporation	$ 0.1349 (92.71%)	122.1k
YIBOPlanet Image International Ltd	$ 2.915 (53.43%)	260.07k
CREVCarbon Revolution Public Ltd	$ 9.00 (45.87%)	8.06M
NMHINatures Miracle Holding Inc	$ 0.2035 (-48.06%)	7.69M
TANHTantech Holdings Ltd	$ 0.2585 (-47.23%)	6.75M
DXCMDexCom Inc	$ 64.00 (-40.66%)	53.92M
PSIGPS International Group Ltd	$ 1.42 (-31.40%)	716.26k
POAIPredictive Oncology Inc	$ 1.36 (-27.27%)	6.02M
SLNASelina Hospitality PLC	$ 0.0305 (-18.88%)	408.61M
BFIBurgerFi International Inc	$ 0.4206 (97.37%)	313.59M
NVDANVIDIA Corporation	$ 113.06 (0.69%)	293.33M
SQQQProShares UltraPro Short QQQ	$ 9.10 (-2.88%)	176.49M
SGMOSangamo Therapeutics Inc	$ 0.8612 (28.15%)	123.71M